SG11202008957VA - Tissue-specific methylation marker - Google Patents
Tissue-specific methylation markerInfo
- Publication number
- SG11202008957VA SG11202008957VA SG11202008957VA SG11202008957VA SG11202008957VA SG 11202008957V A SG11202008957V A SG 11202008957VA SG 11202008957V A SG11202008957V A SG 11202008957VA SG 11202008957V A SG11202008957V A SG 11202008957VA SG 11202008957V A SG11202008957V A SG 11202008957VA
- Authority
- SG
- Singapore
- Prior art keywords
- tissue
- specific methylation
- methylation marker
- marker
- specific
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/30—Drug targeting using structural data; Docking or binding prediction
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862643649P | 2018-03-15 | 2018-03-15 | |
| US201862769928P | 2018-11-20 | 2018-11-20 | |
| PCT/US2019/022504 WO2019178496A1 (en) | 2018-03-15 | 2019-03-15 | Tissue-specific methylation marker |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202008957VA true SG11202008957VA (en) | 2020-10-29 |
Family
ID=67908065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202008957VA SG11202008957VA (en) | 2018-03-15 | 2019-03-15 | Tissue-specific methylation marker |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11884966B2 (en) |
| EP (1) | EP3766076A4 (en) |
| JP (1) | JP2021518107A (en) |
| KR (1) | KR20210023804A (en) |
| CN (1) | CN112534506A (en) |
| AU (1) | AU2019233897B2 (en) |
| CA (1) | CA3093971A1 (en) |
| IL (1) | IL277306A (en) |
| PH (1) | PH12020551712A1 (en) |
| SG (1) | SG11202008957VA (en) |
| TW (1) | TWI848941B (en) |
| WO (1) | WO2019178496A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3766076A4 (en) | 2018-03-15 | 2021-12-29 | Grail, Inc. | Tissue-specific methylation marker |
| KR102103885B1 (en) * | 2019-10-08 | 2020-04-24 | 주식회사 레피다인 | Method for Identifying Whether Biological Sample is Derived from Liver Tissue |
| KR102155044B1 (en) * | 2019-10-08 | 2020-09-11 | 주식회사 레피다인 | Method for Identifying Whether Biological Sample is Derived from Liver Cancer Tissue |
| EP4083232A4 (en) * | 2019-12-26 | 2024-03-20 | Anchordx Medical Co., Ltd. | Combination of dna methylation biomarkers, and detection method therefor and kit thereof |
| US20230257822A1 (en) * | 2020-04-24 | 2023-08-17 | Cornell University | Methods for detecting tissue damage, graft versus host disease, and infections using cell-free dna profiling |
| EP4291677A2 (en) | 2021-02-09 | 2023-12-20 | F. Hoffmann-La Roche AG | Methods for base-level detection of methylation in nucleic acids |
| WO2023144704A1 (en) * | 2022-01-25 | 2023-08-03 | Gene Solutions Joint Stock Company | Systems and methods for detecting tumor dna in mammalian blood |
| WO2023242075A1 (en) | 2022-06-14 | 2023-12-21 | F. Hoffmann-La Roche Ag | Detection of epigenetic cytosine modification |
| WO2024112741A1 (en) * | 2022-11-23 | 2024-05-30 | Salk Institute For Biological Studies | Dna methylation barcodes for identifying brain cells |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2646579B1 (en) | 2010-11-30 | 2017-06-14 | The Chinese University Of Hong Kong | Detection of genetic or molecular aberrations associated with cancer |
| US9732390B2 (en) * | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| ES2665273T5 (en) | 2012-09-20 | 2023-10-02 | Univ Hong Kong Chinese | Non-invasive determination of methylome of the fetus or plasma tumor |
| CA2938451C (en) | 2014-01-30 | 2023-10-17 | The Regents Of The University Of California | Methylation haplotyping for non-invasive diagnosis (monod) |
| PL4026917T3 (en) * | 2014-04-14 | 2024-04-08 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | A method and kit for determining the death of cells or tissue or the tissue or cell origin of dna by dna methylation analysis |
| EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
| WO2015169947A1 (en) | 2014-05-09 | 2015-11-12 | Lifecodexx Ag | Detection of dna that originates from a specific cell-type and related methods |
| NZ765010A (en) | 2014-06-04 | 2024-08-30 | Quest Diagnostics Invest Llc | Methylated markers for colorectal cancer |
| DK3543356T3 (en) * | 2014-07-18 | 2021-10-11 | Univ Hong Kong Chinese | Analysis of methylation pattern of tissues in DNA mixture |
| EP3230744B1 (en) * | 2014-12-12 | 2021-05-12 | Exact Sciences Development Company, LLC | Compositions and methods for performing methylation detection assays |
| SI3408407T1 (en) * | 2016-01-29 | 2021-04-30 | Epigenomics Ag | Methods for detecting cpg methylation of tumor-derived dna in blood samples |
| US11499196B2 (en) | 2016-06-07 | 2022-11-15 | The Regents Of The University Of California | Cell-free DNA methylation patterns for disease and condition analysis |
| EP3766076A4 (en) | 2018-03-15 | 2021-12-29 | Grail, Inc. | Tissue-specific methylation marker |
-
2019
- 2019-03-15 EP EP19768415.2A patent/EP3766076A4/en active Pending
- 2019-03-15 CN CN201980032333.3A patent/CN112534506A/en active Pending
- 2019-03-15 SG SG11202008957VA patent/SG11202008957VA/en unknown
- 2019-03-15 JP JP2020548776A patent/JP2021518107A/en active Pending
- 2019-03-15 CA CA3093971A patent/CA3093971A1/en active Pending
- 2019-03-15 US US16/354,799 patent/US11884966B2/en active Active
- 2019-03-15 KR KR1020207029494A patent/KR20210023804A/en active Search and Examination
- 2019-03-15 WO PCT/US2019/022504 patent/WO2019178496A1/en active Application Filing
- 2019-03-15 AU AU2019233897A patent/AU2019233897B2/en active Active
- 2019-03-15 TW TW108108991A patent/TWI848941B/en active
-
2020
- 2020-09-13 IL IL277306A patent/IL277306A/en unknown
- 2020-10-15 PH PH12020551712A patent/PH12020551712A1/en unknown
-
2023
- 2023-12-13 US US18/538,995 patent/US20240191282A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021518107A (en) | 2021-08-02 |
| IL277306A (en) | 2020-10-29 |
| AU2019233897A1 (en) | 2020-10-22 |
| TW202010845A (en) | 2020-03-16 |
| EP3766076A1 (en) | 2021-01-20 |
| EP3766076A4 (en) | 2021-12-29 |
| WO2019178496A1 (en) | 2019-09-19 |
| AU2019233897B2 (en) | 2024-10-24 |
| CN112534506A (en) | 2021-03-19 |
| CA3093971A1 (en) | 2019-09-19 |
| TWI848941B (en) | 2024-07-21 |
| US20190390257A1 (en) | 2019-12-26 |
| PH12020551712A1 (en) | 2021-06-21 |
| US11884966B2 (en) | 2024-01-30 |
| US20240191282A1 (en) | 2024-06-13 |
| KR20210023804A (en) | 2021-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277306A (en) | Tissue-specific methylation marker | |
| IL283308A (en) | Positioning marker | |
| GB201505864D0 (en) | Live markers | |
| PL3810587T3 (en) | Substituted alkoxypyridinyl indolsulfonamides | |
| EP3828291A4 (en) | Methylation modification-based tumor marker stamp-ep1 | |
| GB2576486B (en) | Coupler | |
| SG11202012126UA (en) | Magnetic marker | |
| EP3828273A4 (en) | Methylation modification-based tumor marker stamp-ep2 | |
| GB2576131B (en) | Coupler | |
| GB201806174D0 (en) | Improved downlighter | |
| EP3950945A4 (en) | Methylation modification-based tumor marker stamp-ep4 | |
| EP3904516A4 (en) | Methylation modification-based tumor marker stamp-ep6 | |
| GB201808868D0 (en) | Binder | |
| EP3750824C0 (en) | Binder | |
| GB2612533B (en) | Coupler | |
| GB2610148B (en) | Coupler | |
| PL3414999T3 (en) | Building for breeding pigs | |
| GB201820629D0 (en) | Marker | |
| GB201804618D0 (en) | Novel Marker | |
| ZA202106802B (en) | Security markers | |
| GB2570969B (en) | Improved location marker device | |
| GB2577060B (en) | Adaptor | |
| GB2610146B (en) | Coupler | |
| GB2610147B (en) | Coupler | |
| IL262778A (en) | U tern vinker |